ArticleTherapeutic advances in medical oncology2022

Systematic review and cost-effectiveness of pharmacokinetically guided sunitinib individualized treatment for patients with metastatic renal cell carcinoma.

Tingting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.